Chromosomal Microarray, Prenatal
| Label Mnemonic: | CMAPD |
| Epic code: | LAB8136 |
| Downtime form: | Doctor/Provider Orders - Pathology Core and Specialty Care Nursery |
Commercial Mailout Laboratory
6240-8 RCP
356-8593
6240-8 RCP
356-8593
Specimen(s):
Amniotic Fluid or CVS
Specimen
Instructions:
For all specimens, the Chromosomal Microarray Prenatal Patient Information and the Informed Consent for Genetic Testing must be filled out and accompany them (available from www.mayomedicallaboratories.com).
Preferred specimens:
- Collect 20–30 mL amniotic fluid (min: 12 mL, more if ordering in conjunction with other tests). Discard first 2 mL of amniotic fluid. Optimal timing for collection is 14-18 weeks, but collections at other gestational weeks accepted.
- Also accepted: 20–30 mg Chorionic Villi in a 15-mL tube containing 15 mL transport media (including but not limited to culture media such as RPMI 1640, Chang's, or AmnioMAX or saline solution such as Hanks' balanced salt solution). Fixative mediums such as alcohol or formalin are not acceptable. Collect by transabdominal or transcervical method. Transfer chorionic villi to a Petri dish containing 15 mL of transport media. Using a stereomicroscope and sterile forceps, assess the quality and quantity of the villi and remove any blood clots and materal decidua.
Minimum:
Submit only ONE of the following preferred specimens:
20-30 mL Amniotic Fluid
20-30 mg Chorionic villi
Absolute Minimum: 5 mL
Rejection Criteria:
Bloody specimens are undesirable.
Turn Around
Time:
10 days upon receipt at reference laboratory
Reference Range:
An interpretive report will be provided.
Methodology:
Chromosomal Microarray (CMA) using Affymetrix Cytoscan HD
CPT Code:
81229
Please print, complete and submit the Chromosomal Microarray Prenatal Patient Information and the Informed Consent for Genetic Testing from Mayo Medical Laboratories with the specimen.
Useful for:
Prenatal diagnosis of copy number changes (gains or losses) across the entire genome.
Determining the size, precise breakpoints, gene content, and any unappreciated complexity of abnormalities detected by other methods such as conventional chromosome and FISH studies.
Determining if apparently balanced abnormalities identified by previous conventional chromosome studies have cryptic imbalances, since a proportion of such rearrangements that appear balanced at the resolution of a chromosome study are actually unbalanced when analyzed by higher-resolution chromosomal microarray.
Assessing regions of homozygosity related to uniparental disomy or identity by descent.
Cautions:
This test does not detect balanced chromosome rearrangements such as Robertsonian or other reciprocal translocations, inversions, or balanced insertions. These abnormalities may be identified by chromosome analysis.
This test does not detect all types and instances of uniparental disomy.
This test is not designed to detect low-level mosaicism, although it can be detected in some cases.
This test does not detect point mutations, small deletions or insertions below the resolution of this assay, or other types of mutations such as epigenetic changes.
The results of this test may be of uncertain clinical significance. In such cases, studies of additional family members may be required to help interpret the results.